Cronos Group Inc (NASDAQ:CRON) Shares Sold by Public Sector Pension Investment Board

Public Sector Pension Investment Board cut its stake in shares of Cronos Group Inc (NASDAQ:CRON) by 2.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 478,200 shares of the company’s stock after selling 14,300 shares during the quarter. Public Sector Pension Investment Board owned 0.14% of Cronos Group worth $3,677,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Evoke Wealth LLC bought a new position in shares of Cronos Group in the 3rd quarter worth $26,000. Rockefeller Capital Management L.P. boosted its holdings in Cronos Group by 80.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 3,792 shares of the company’s stock worth $29,000 after buying an additional 1,692 shares during the period. FinTrust Capital Advisors LLC boosted its holdings in Cronos Group by 2,080.0% in the 4th quarter. FinTrust Capital Advisors LLC now owns 4,360 shares of the company’s stock worth $33,000 after buying an additional 4,160 shares during the period. Penserra Capital Management LLC bought a new position in Cronos Group in the 3rd quarter worth approximately $72,000. Finally, Tower Research Capital LLC TRC boosted its holdings in Cronos Group by 2,812.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,736 shares of the company’s stock worth $67,000 after buying an additional 8,436 shares during the period. 14.37% of the stock is owned by hedge funds and other institutional investors.

CRON has been the subject of several analyst reports. ValuEngine raised shares of Cronos Group from a “hold” rating to a “buy” rating in a report on Tuesday, December 3rd. Zacks Investment Research raised shares of Cronos Group from a “hold” rating to a “buy” rating and set a $6.00 price objective for the company in a research note on Tuesday, March 17th. Stifel Nicolaus cut shares of Cronos Group from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $12.00 to $8.00 in a research note on Tuesday, March 3rd. BidaskClub raised shares of Cronos Group from a “strong sell” rating to a “sell” rating in a research note on Wednesday, March 18th. Finally, Raymond James set a $12.00 price objective on shares of Cronos Group and gave the stock an “outperform” rating in a research note on Saturday, December 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company’s stock. Cronos Group currently has an average rating of “Hold” and a consensus target price of $14.78.

Shares of NASDAQ CRON traded up $0.69 during midday trading on Thursday, hitting $6.32. The stock had a trading volume of 550,272 shares, compared to its average volume of 6,822,344. The company has a market capitalization of $1.91 billion, a price-to-earnings ratio of 7.26 and a beta of 3.03. Cronos Group Inc has a 1-year low of $4.00 and a 1-year high of $20.74. The company has a fifty day moving average price of $6.23 and a 200 day moving average price of $7.65.

Cronos Group Profile

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

See Also: Cost of Goods Sold (COGS)

Institutional Ownership by Quarter for Cronos Group (NASDAQ:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.